AbbVie (ABBV) Receivables (2012 - 2026)
AbbVie (ABBV) reported Receivables of $13.82 billion for Q2 2026, up 9.4% from $12.64 billion a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie posted Receivables of $12.59 billion, up 15.3% from FY2024.
- Receivables has a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- By year, Receivables came in at $10.92 billion in FY2024 (-2.1%), $11.16 billion in FY2023 (-0.9%), $11.25 billion in FY2022 (+12.8%) and $9.98 billion in FY2021 (+13.1%).
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q4 2012.
- Year over year, Receivables gained in six of the last eight quarters, with growth averaging 5.8%.
- The high point for year-over-year Receivables in five years was Q3 2022 (growth of 15.8%); the low point was Q4 2024 (a decline of 2.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.48 billion (Q1 2026), $12.59 billion (Q4 2025) and $12.77 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 Bn |
| Mar 31, 2026 | 12.48 Bn |
| Dec 31, 2025 | 12.59 Bn |
| Sep 30, 2025 | 12.77 Bn |
| Jun 30, 2025 | 12.64 Bn |
| Mar 31, 2025 | 12.48 Bn |
| Dec 31, 2024 | 10.92 Bn |
| Sep 30, 2024 | 11.47 Bn |
| Jun 30, 2024 | 11.72 Bn |
| Mar 31, 2024 | 11.95 Bn |
| Dec 31, 2023 | 11.16 Bn |
| Sep 30, 2023 | 11.41 Bn |
| Jun 30, 2023 | 11.49 Bn |
| Mar 31, 2023 | 11.47 Bn |
| Dec 31, 2022 | 11.25 Bn |
| Sep 30, 2022 | 10.74 Bn |
| Jun 30, 2022 | 11.24 Bn |
| Mar 31, 2022 | 10.73 Bn |
| Dec 31, 2021 | 9.98 Bn |
| Sep 30, 2021 | 9.28 Bn |
API Access
AbbVie Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();